NYHA Class IV Approval: In August 2024, scPharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted approval for FUROSCIX, expanding the indication to include New York Heart ...
Dr. Charles Puza, a board-certified NYC dermatologist, is sharing a very worrisome concern about space heaters — they could cause a condition called erythema ab igne, also known as “EAI,” ...
The treatment for keratosis pilaris is continuous. The condition needs to be maintained. General measures to prevent ...
Hot water bottles are generally safe, but some medical professionals advise against using them in too close contact with skin ...
Slapped cheek disease also called fifth disease is a contagious viral infection common in children Read to know all about the ...
Dr. Charles Puza, a board-certified NYC dermatologist, is sharing a very worrisome concern about space heaters — they could ...
DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...
The U.S. Food and Drug Administration has approved Journey Medical's drug for the treatment of a long-term skin condition ...
A 58-year-old woman with hypertension and diabetes presented with a persistent annular erythema on her left thigh for more than 10 years. She had been diagnosed with tinea corporis and contact ...
Continuing our series dispelling some common myths about conditions managed by nurses in primary care, Dr Peter ...
Fifth disease (erythema infectiosum) is a viral infection caused by parvovirus B19. It causes a red cheek rash, earning the name "slapped cheek disease." ...
The FDA is set to decide on four promising therapies in the next two weeks, including a CAR T for acute lymphoblastic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback